• ქართული
  • English
  • France's Sanofi to carve out active drug ingredients firm

    Sanofi plans to create a standalone company dedicated to making active pharmaceutical ingredients (API), components that are biologically active in a drug, and will decide whether to list it on Euronext Paris by 2022.

    Market Quotes by TradingView